Does DEGARELIX Cause Injection site nodule? 37 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Injection site nodule have been filed in association with DEGARELIX (FIRMAGON). This represents 1.0% of all adverse event reports for DEGARELIX.
37
Reports of Injection site nodule with DEGARELIX
1.0%
of all DEGARELIX reports
3
Deaths
13
Hospitalizations
How Dangerous Is Injection site nodule From DEGARELIX?
Of the 37 reports, 3 (8.1%) resulted in death, 13 (35.1%) required hospitalization.
Is Injection site nodule Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEGARELIX. However, 37 reports have been filed with the FAERS database.
What Other Side Effects Does DEGARELIX Cause?
Injection site pain (296)
Injection site erythema (246)
Hot flush (199)
Fatigue (195)
Injection site swelling (183)
Product storage error (177)
Pyrexia (170)
Off label use (128)
Asthenia (123)
Death (120)
What Other Drugs Cause Injection site nodule?
EXENATIDE (2,167)
HYDROXYPROGESTERONE CAPROATE (425)
ADALIMUMAB (364)
PALIPERIDONE (313)
DUPILUMAB (271)
BYDUREON (241)
ETANERCEPT (215)
CABOTEGRAVIR (178)
NALTREXONE (154)
CABOTEGRAVIR\RILPIVIRINE (153)
Which DEGARELIX Alternatives Have Lower Injection site nodule Risk?
DEGARELIX vs DELAFLOXACIN MEGLUMINE
DEGARELIX vs DELAMANID
DEGARELIX vs DELANDISTROGENE MOXEPARVOVEC-ROKL
DEGARELIX vs DELAVIRDINE
DEGARELIX vs DELORAZEPAM